Abstract
Henning Schäfer, Ahmad Idrissi-Yaghir, Kamyar Arzideh, Hendrik Damm, Tabea M.G. Pakull, Cynthia S. Schmidt, Mikel Bahn, Georg Lodde, Elisabeth Livingstone, Dirk Schadendorf, Felix Nensa, Peter A. Horn, Christoph M. Friedrich
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
Big data in healthcare: management, analysis and future prospects
10.1186/s40537-019-0217-0 · 2019
Towards a definition of knowledge graphs
2016
10.1145/1242572.1242667
10.1145/1242572.1242667 · 2007
Knowledge graphs and knowledge networks: the story in brief
10.1109/mic.2019.2928449 · 2019
10.1016/j.csbj.2020.05.017
10.1016/j.csbj.2020.05.017
10.1007/s11192-010-0202-z
10.1007/s11192-010-0202-z
Real-world data medical knowledge graph: construction and applications
10.1016/j.artmed.2020.101817 · 2020
Re-curation and rational enrichment of knowledge graphs in biological expression language
10.1093/database/baz068 · 2019
LocText: relation extraction of protein localizations to assist database curation
10.1186/s12859-018-2021-9 · 2018
Constructing biomedical domain-specific knowledge graph with minimum supervision
10.1007/s10115-019-01351-4 · 2020
10.1109/tkde.2017.2754499
10.1109/tkde.2017.2754499
Kidney precision medicine project, modelling kidney disease using ontology: insights from the kidney precision medicine project
10.1038/s41581-020-00335-w · 2020
10.1016/j.jbi.2022.104133
10.1016/j.jbi.2022.104133
EMR-based medical knowledge representation and inference via Markov random fields and distributed representation learning
10.1016/j.artmed.2018.03.005 · 2018
Improving rare disease classification using imperfect knowledge graph
10.1186/s12911-019-0938-1 · 2019
Biomedical knowledge graph embeddings for personalized medicine: predicting disease-gene associations
10.1111/exsy.13181 · 2023
10.1038/s41597-023-01960-3
10.1038/s41597-023-01960-3
10.1093/annonc/mdx528
10.1093/annonc/mdx528
Unresolved referenced work
2019
10.1145/3289600.3290956
10.1145/3289600.3290956 · 2019
Unifying large language models and knowledge graphs: a roadmap
10.1109/tkde.2024.3352100 · 2024
Enriching contextualized language model from knowledge graph for biomedical information extraction
10.1093/bib/bbaa110 · 2020
10.18653/v1/2021.bionlp-1.20
10.18653/v1/2021.bionlp-1.20 · 2021
A survey of knowledge enhanced pre-trained language models
10.1109/tkde.2023.3310002 · 2024
SMR: medical knowledge graph embedding for safe medicine recommendation
10.1016/j.bdr.2020.100174 · 2021
BioBERT: a pre-trained biomedical language representation model for biomedical text mining
10.1093/bioinformatics/btz682 · 2019
Unresolved referenced work
2019
Domain-specific language model pretraining for biomedical natural language processing
2021
10.18653/v1/2021.emnlp-main.383
10.18653/v1/2021.emnlp-main.383 · 2021
Unresolved referenced work
2021
10.1093/nar/gkh061
10.1093/nar/gkh061
Unresolved referenced work
2001
A comprehensive survey on automatic knowledge graph construction
2023
Healthcare knowledge graph construction: a systematic review of the state-of-the-art, open issues, and opportunities
10.1186/s40537-023-00774-9 · 2023
Named entity extraction for knowledge graphs: a literature overview
10.1109/access.2020.2973928 · 2020
Deep neural approaches to relation triplets extraction: a comprehensive survey
10.1007/s12559-021-09917-7 · 2021
Knowledge graph refinement: a survey of approaches and evaluation methods
2017
10.1136/jamia.2009.002733
10.1136/jamia.2009.002733
SemEHR: a general-purpose semantic search system to surface semantic data from clinical notes for tailored care, trial recruitment, and clinical research
10.1093/jamia/ocx160 · 2018
Mayo clinical text analysis and knowledge extraction system (cTAKES): architecture, component evaluation and applications
10.1136/jamia.2009.001560 · 2010
Treatment of primary cutaneous B-cell lymphoma with rituximab
10.1016/j.jaad.2005.01.093 · doi-reference
Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study
10.1093/annonc/mdq418 · doi-reference
Rituximab therapy in monoclonal IgM-related neuropathies
10.1080/14786410500441664 · doi-reference
Rituximab in relapsed or refractory hairy cell leukemia
10.1182/blood-2003-02-0630 · doi-reference
Rituximab therapy in hematologic malignancy patients with circulating blood tumor cells: association with increased infusion-related side effects and rapid blood tumor clearance
10.1200/jco.1999.17.3.791 · doi-reference
Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the minnie pearl cancer research network
10.1200/jco.2003.09.027 · doi-reference
A pilot study of rituximab in patients with recurrent, classic Hodgkin disease
10.1002/cncr.11511 · doi-reference
Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial
10.1182/blood-2014-03-563627 · doi-reference
Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly
10.1093/annonc/mdq712 · doi-reference
Fixed duration of venetoclax-rituximab in relapsed/refractory chronic lymphocytic leukemia eradicates minimal residual disease and prolongs survival: post-treatment follow-up of the MURANO phase III study
10.1200/jco.18.01580 · doi-reference
Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma
10.1016/j.bbmt.2006.07.007 · doi-reference
Primary therapy of Waldenström macroglobulinemia with bortezomib, dexamethasone, and rituximab: WMCTG clinical trial 05-180
10.1200/jco.2008.20.4677 · doi-reference
Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type
10.1182/blood-2002-11-3496 · doi-reference
Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study
10.1182/blood-2005-01-0377 · doi-reference
Treatment of older patients with mantle-cell lymphoma
10.1056/nejmoa1200920 · doi-reference
Rituximab therapy in malignant lymphoma
10.1038/sj.onc.1210376 · doi-reference
10.1056/nejmoa1713976
10.1056/nejmoa1713976 · doi-reference
Rituximab maintenance for the treatment of patients with follicular lymphoma: an updated systematic review and meta-analysis of randomized trials
10.1093/jnci/djr418 · doi-reference
10.1016/j.jaut.2014.12.002
10.1016/j.jaut.2014.12.002 · doi-reference
10.1007/s12325-017-0612-x
10.1007/s12325-017-0612-x · doi-reference
10.1016/s0140-6736(21)00797-2
10.1016/s0140-6736(21)00797-2 · doi-reference
10.1016/s1470-2045(21)00604-5
10.1016/s1470-2045(21)00604-5 · doi-reference
Novel adjuvant options for cutaneous melanoma
10.1016/j.annonc.2021.03.198 · doi-reference
10.1056/nejmoa1411087
10.1056/nejmoa1411087 · doi-reference
10.1056/nejmoa1805453
10.1056/nejmoa1805453 · doi-reference
10.1056/nejmoa1602252
10.1056/nejmoa1602252 · doi-reference
10.1016/s0140-6736(17)31827-5
10.1016/s0140-6736(17)31827-5 · doi-reference
10.1056/nejmoa1510665
10.1056/nejmoa1510665 · doi-reference
Safety and efficacy of nivolumab in patients with advanced clear cell renal cell carcinoma: results from the phase IIIb/IV CheckMate 374 study
10.1016/j.clgc.2020.06.002 · doi-reference
10.1200/jco.2014.59.0703
10.1200/jco.2014.59.0703 · doi-reference
10.1056/nejmoa1910231
10.1056/nejmoa1910231 · doi-reference
10.1056/nejmoa1504030
10.1056/nejmoa1504030 · doi-reference
10.1016/s0004-3702(97)00008-8
10.1016/s0004-3702(97)00008-8 · doi-reference
10.1038/nrd.2018.168
10.1038/nrd.2018.168 · doi-reference
10.1016/j.cell.2011.02.013
10.1016/j.cell.2011.02.013 · doi-reference
10.1016/s0092-8674(00)81683-9
10.1016/s0092-8674(00)81683-9 · doi-reference
10.18653/v1/w17-2339
10.18653/v1/w17-2339 · doi-reference
10.1093/bioinformatics/btx454
10.1093/bioinformatics/btx454 · doi-reference
Automatic semantic classification of scientific literature according to the hallmarks of cancer
10.1093/bioinformatics/btv585 · doi-reference
A fast and high quality multilevel scheme for partitioning irregular graphs
10.1137/s1064827595287997 · doi-reference